Omada Health (NASDAQ: OMDA) Stock Competitors & Peer Comparison
See OMDA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OMDA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OMDA | $15.09 | -20.37% | 922.8M | 65.54 | $0.23 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $76.05 | +7.98% | 13.5B | -152.08 | -$0.50 | N/A |
| BTSGU | $212.10 | -1.95% | 13.4B | 129.05 | $1.71 | N/A |
| BTSG | $67.15 | +1.96% | 13.4B | 39.26 | $1.71 | N/A |
| HNGE | $115.76 | -0.19% | 9.3B | 61.90 | $1.87 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $103.63 | +0.16% | 8.6B | 24.20 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $32.51 | -2.02% | 5.8B | 21.25 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
OMDA vs GEHCV Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas GEHCV's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to GEHCV's ROE of +0.20%. Regarding short-term risk, OMDA is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
OMDA vs TEM Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, TEM has a market cap of 13.5B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while TEM trades at $76.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas TEM's P/E ratio is -152.08. In terms of profitability, OMDA's ROE is +0.02%, compared to TEM's ROE of -0.41%. Regarding short-term risk, OMDA is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TEM's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
OMDA vs BTSGU Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, BTSGU has a market cap of 13.4B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while BTSGU trades at $212.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas BTSGU's P/E ratio is 129.05. In terms of profitability, OMDA's ROE is +0.02%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, OMDA is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
OMDA vs BTSG Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, BTSG has a market cap of 13.4B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while BTSG trades at $67.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas BTSG's P/E ratio is 39.26. In terms of profitability, OMDA's ROE is +0.02%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, OMDA is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BTSG's competition here
Hinge Health, Inc. (NYSE: HNGE)
OMDA vs HNGE Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, HNGE has a market cap of 9.3B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while HNGE trades at $115.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas HNGE's P/E ratio is 61.90. In terms of profitability, OMDA's ROE is +0.02%, compared to HNGE's ROE of +0.50%. Regarding short-term risk, OMDA is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HNGE's competition here
Signify Health, Inc. (NYSE: SGFY)
OMDA vs SGFY Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SGFY's P/E ratio is 70.91. In terms of profitability, OMDA's ROE is +0.02%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, OMDA is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
OMDA vs HQY Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, HQY has a market cap of 8.6B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while HQY trades at $103.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas HQY's P/E ratio is 24.20. In terms of profitability, OMDA's ROE is +0.02%, compared to HQY's ROE of +0.11%. Regarding short-term risk, OMDA is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
OMDA vs RCM Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas RCM's P/E ratio is -102.21. In terms of profitability, OMDA's ROE is +0.02%, compared to RCM's ROE of +0.00%. Regarding short-term risk, OMDA is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
OMDA vs DOCS Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, DOCS has a market cap of 5.8B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while DOCS trades at $32.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas DOCS's P/E ratio is 21.25. In terms of profitability, OMDA's ROE is +0.02%, compared to DOCS's ROE of +0.15%. Regarding short-term risk, OMDA is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
OMDA vs WAY Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, WAY has a market cap of 5.5B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while WAY trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas WAY's P/E ratio is 18.77. In terms of profitability, OMDA's ROE is +0.02%, compared to WAY's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
OMDA vs HTFL Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, HTFL has a market cap of 4.6B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while HTFL trades at $52.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas HTFL's P/E ratio is -26.07. In terms of profitability, OMDA's ROE is +0.02%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, OMDA is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
OMDA vs ONEM Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ONEM's P/E ratio is -7.77. In terms of profitability, OMDA's ROE is +0.02%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, OMDA is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
OMDA vs PRVA Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while PRVA trades at $24.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas PRVA's P/E ratio is 116.33. In terms of profitability, OMDA's ROE is +0.02%, compared to PRVA's ROE of +0.05%. Regarding short-term risk, OMDA is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check PRVA's competition here
Certara, Inc. (NASDAQ: CERT)
OMDA vs CERT Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CERT has a market cap of 1.8B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CERT trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CERT's P/E ratio is 30.07. In terms of profitability, OMDA's ROE is +0.02%, compared to CERT's ROE of -0.06%. Regarding short-term risk, OMDA is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CERT's competition here
Omnicell, Inc. (NASDAQ: OMCL)
OMDA vs OMCL Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while OMCL trades at $37.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas OMCL's P/E ratio is 19.57. In terms of profitability, OMDA's ROE is +0.02%, compared to OMCL's ROE of +0.04%. Regarding short-term risk, OMDA is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check OMCL's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
OMDA vs NXGN Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas NXGN's P/E ratio is -266.00. In terms of profitability, OMDA's ROE is +0.02%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, OMDA is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
OMDA vs TDOC Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas TDOC's P/E ratio is -10.17. In terms of profitability, OMDA's ROE is +0.02%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, OMDA is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
OMDA vs AGTI Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas AGTI's P/E ratio is -71.79. In terms of profitability, OMDA's ROE is +0.02%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, OMDA is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
OMDA vs GDRX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while GDRX trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas GDRX's P/E ratio is 11.00. In terms of profitability, OMDA's ROE is +0.02%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check GDRX's competition here
HealthStream, Inc. (NASDAQ: HSTM)
OMDA vs HSTM Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, HSTM has a market cap of 883M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while HSTM trades at $28.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas HSTM's P/E ratio is 40.08. In terms of profitability, OMDA's ROE is +0.02%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, OMDA is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
OMDA vs CCLDO Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CCLDO's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CCLDO's ROE of +0.24%. Regarding short-term risk, OMDA is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
OMDA vs PHR Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, PHR has a market cap of 783.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas PHR's P/E ratio is 45.09. In terms of profitability, OMDA's ROE is +0.02%, compared to PHR's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
OMDA vs MPLN-WT Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, OMDA is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MPLN-WT's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
OMDA vs SOPH Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SOPH has a market cap of 607.8M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SOPH trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SOPH's P/E ratio is -6.43. In terms of profitability, OMDA's ROE is +0.02%, compared to SOPH's ROE of -1.33%. Regarding short-term risk, OMDA is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SOPH's competition here
Accolade, Inc. (NASDAQ: ACCD)
OMDA vs ACCD Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ACCD's P/E ratio is -3.08. In terms of profitability, OMDA's ROE is +0.02%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, OMDA is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ACCD's competition here
NRC Health (NASDAQ: NRC)
OMDA vs NRC Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, NRC has a market cap of 572M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while NRC trades at $25.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas NRC's P/E ratio is 31.54. In terms of profitability, OMDA's ROE is +0.02%, compared to NRC's ROE of +1.03%. Regarding short-term risk, OMDA is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check NRC's competition here
Sharecare, Inc. (NASDAQ: SHCR)
OMDA vs SHCR Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SHCR's P/E ratio is -3.76. In terms of profitability, OMDA's ROE is +0.02%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, OMDA is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
OMDA vs EVH Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, EVH has a market cap of 514M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while EVH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas EVH's P/E ratio is 35.15. In terms of profitability, OMDA's ROE is +0.02%, compared to EVH's ROE of -1.30%. Regarding short-term risk, OMDA is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check EVH's competition here
Carlsmed, Inc. (NASDAQ: CARL)
OMDA vs CARL Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CARL has a market cap of 396.4M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CARL trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CARL's P/E ratio is -10.15. In terms of profitability, OMDA's ROE is +0.02%, compared to CARL's ROE of -0.38%. Regarding short-term risk, OMDA is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CARL's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
OMDA vs SLGC Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SLGC's P/E ratio is -3.04. In terms of profitability, OMDA's ROE is +0.02%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, OMDA is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
OMDA vs SLGCW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, OMDA's ROE is +0.02%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, OMDA is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
OMDA vs TBRG Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas TBRG's P/E ratio is 9.37. In terms of profitability, OMDA's ROE is +0.02%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, OMDA is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TBRG's competition here
Claritev Corporation (NYSE: CTEV)
OMDA vs CTEV Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CTEV has a market cap of 386.7M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CTEV trades at $22.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CTEV's P/E ratio is -1.34. In terms of profitability, OMDA's ROE is +0.02%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, OMDA is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN)
OMDA vs MPLN Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MPLN's P/E ratio is -0.23. In terms of profitability, OMDA's ROE is +0.02%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, OMDA is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
OMDA vs TRHC Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas TRHC's P/E ratio is -4.27. In terms of profitability, OMDA's ROE is +0.02%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, OMDA is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
OMDA vs SY Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SY has a market cap of 268.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SY trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SY's P/E ratio is -6.21. In terms of profitability, OMDA's ROE is +0.02%, compared to SY's ROE of -0.16%. Regarding short-term risk, OMDA is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
OMDA vs SMFR Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SMFR's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
OMDA vs SPOK Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SPOK has a market cap of 245.2M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SPOK trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SPOK's P/E ratio is 13.19. In terms of profitability, OMDA's ROE is +0.02%, compared to SPOK's ROE of +0.13%. Regarding short-term risk, OMDA is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
OMDA vs AMWL Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, AMWL has a market cap of 183.9M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while AMWL trades at $11.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas AMWL's P/E ratio is -2.71. In terms of profitability, OMDA's ROE is +0.02%, compared to AMWL's ROE of -0.25%. Regarding short-term risk, OMDA is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
OMDA vs OPRX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while OPRX trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas OPRX's P/E ratio is 8.03. In terms of profitability, OMDA's ROE is +0.02%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, OMDA is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
OMDA vs LFMDP Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, LFMDP has a market cap of 145.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while LFMDP trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas LFMDP's P/E ratio is -655.78. In terms of profitability, OMDA's ROE is +0.02%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, OMDA is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LFMDP's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
OMDA vs CPSI Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CPSI's P/E ratio is -183.80. In terms of profitability, OMDA's ROE is +0.02%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, OMDA is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CPSI's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
OMDA vs DH Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, DH has a market cap of 121.7M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while DH trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas DH's P/E ratio is 4.38. In terms of profitability, OMDA's ROE is +0.02%, compared to DH's ROE of -0.83%. Regarding short-term risk, OMDA is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check DH's competition here
Augmedix, Inc. (NASDAQ: AUGX)
OMDA vs AUGX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas AUGX's P/E ratio is -4.99. In terms of profitability, OMDA's ROE is +0.02%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, OMDA is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AUGX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
OMDA vs LFMD Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, LFMD has a market cap of 114.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while LFMD trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas LFMD's P/E ratio is -4.73. In terms of profitability, OMDA's ROE is +0.02%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, OMDA is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LFMD's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
OMDA vs HCAT Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, HCAT has a market cap of 110.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while HCAT trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas HCAT's P/E ratio is 7.35. In terms of profitability, OMDA's ROE is +0.02%, compared to HCAT's ROE of -1.28%. Regarding short-term risk, OMDA is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HCAT's competition here
CareCloud, Inc. (NASDAQ: CCLD)
OMDA vs CCLD Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CCLD has a market cap of 96.9M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CCLD trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CCLD's P/E ratio is 8.77. In terms of profitability, OMDA's ROE is +0.02%, compared to CCLD's ROE of +0.24%. Regarding short-term risk, OMDA is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check CCLD's competition here
Forian Inc. (NASDAQ: FORA)
OMDA vs FORA Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas FORA's P/E ratio is -24.11. In terms of profitability, OMDA's ROE is +0.02%, compared to FORA's ROE of -0.17%. Regarding short-term risk, OMDA is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
OMDA vs CCLDP Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CCLDP's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CCLDP's ROE of +0.24%. Regarding short-term risk, OMDA is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
OMDA vs SNCE Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SNCE's P/E ratio is -0.27. In terms of profitability, OMDA's ROE is +0.02%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, OMDA is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
OMDA vs AKLI Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas AKLI's P/E ratio is -0.71. In terms of profitability, OMDA's ROE is +0.02%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, OMDA is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
OMDA vs SHLT Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SHLT's P/E ratio is -3.87. In terms of profitability, OMDA's ROE is +0.02%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, OMDA is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
OMDA vs SHCRW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, OMDA is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMD)
OMDA vs ONMD Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ONMD has a market cap of 29.7M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ONMD trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ONMD's P/E ratio is -31.87. In terms of profitability, OMDA's ROE is +0.02%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, OMDA is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ONMD's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
OMDA vs STRM Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas STRM's P/E ratio is -2.40. In terms of profitability, OMDA's ROE is +0.02%, compared to STRM's ROE of -0.65%. Regarding short-term risk, OMDA is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
OMDA vs RNLX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas RNLX's P/E ratio is -0.33. In terms of profitability, OMDA's ROE is +0.02%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, OMDA is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
OMDA vs LIFW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas LIFW's P/E ratio is -0.02. In terms of profitability, OMDA's ROE is +0.02%, compared to LIFW's ROE of +0.81%. Regarding short-term risk, OMDA is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LIFW's competition here
SCWorx Corp. (NASDAQ: WORX)
OMDA vs WORX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, WORX has a market cap of 20.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while WORX trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas WORX's P/E ratio is -1.50. In terms of profitability, OMDA's ROE is +0.02%, compared to WORX's ROE of -0.35%. Regarding short-term risk, OMDA is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check WORX's competition here
Babylon Holdings Limited (NYSE: BBLN)
OMDA vs BBLN Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas BBLN's P/E ratio is -0.04. In terms of profitability, OMDA's ROE is +0.02%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, OMDA is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check BBLN's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
OMDA vs ONMDW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ONMDW has a market cap of 9.9M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ONMDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ONMDW's P/E ratio is -0.07. In terms of profitability, OMDA's ROE is +0.02%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, OMDA is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ONMDW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
OMDA vs ETAO Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ETAO's P/E ratio is -0.01. In terms of profitability, OMDA's ROE is +0.02%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, OMDA is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
OMDA vs BFRG Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, BFRG has a market cap of 9.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while BFRG trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas BFRG's P/E ratio is -1.13. In terms of profitability, OMDA's ROE is +0.02%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, OMDA is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BFRG's competition here
UpHealth, Inc. (NYSE: UPH-WT)
OMDA vs UPH-WT Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to UPH-WT's ROE of -0.72%. Regarding short-term risk, OMDA is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
OMDA vs UPH Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas UPH's P/E ratio is -0.07. In terms of profitability, OMDA's ROE is +0.02%, compared to UPH's ROE of -1.05%. Regarding short-term risk, OMDA is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check UPH's competition here
Aclarion, Inc. (NASDAQ: ACON)
OMDA vs ACON Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ACON has a market cap of 4.9M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ACON trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ACON's P/E ratio is -0.19. In terms of profitability, OMDA's ROE is +0.02%, compared to ACON's ROE of -0.63%. Regarding short-term risk, OMDA is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ACON's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
OMDA vs MGRX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MGRX has a market cap of 4.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MGRX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MGRX's P/E ratio is -0.14. In terms of profitability, OMDA's ROE is +0.02%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, OMDA is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
OMDA vs PEAR Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas PEAR's P/E ratio is -0.08. In terms of profitability, OMDA's ROE is +0.02%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
OMDA vs PEARW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas PEARW's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check PEARW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
OMDA vs HCTI Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, HCTI has a market cap of 2.8M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while HCTI trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas HCTI's P/E ratio is -0.47. In terms of profitability, OMDA's ROE is +0.02%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, OMDA is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HCTI's competition here
Ontrak, Inc. (NASDAQ: OTRK)
OMDA vs OTRK Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas OTRK's P/E ratio is -0.02. In terms of profitability, OMDA's ROE is +0.02%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, OMDA is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
OMDA vs CMAX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CMAX's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, OMDA is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
OMDA vs BFRGW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, BFRGW has a market cap of 1.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas BFRGW's P/E ratio is -0.22. In terms of profitability, OMDA's ROE is +0.02%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, OMDA is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
OMDA vs LIFWZ Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to LIFWZ's ROE of +0.81%. Regarding short-term risk, OMDA is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
OMDA vs VSEE Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, VSEE has a market cap of 931.2K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while VSEE trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas VSEE's P/E ratio is -2.58. In terms of profitability, OMDA's ROE is +0.02%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, OMDA is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
OMDA vs VSEEW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, OMDA's ROE is +0.02%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, OMDA is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
OMDA vs MSPRZ Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MSPRZ's ROE of +0.81%. Regarding short-term risk, OMDA is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
OMDA vs KERN Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas KERN's P/E ratio is -0.01. In terms of profitability, OMDA's ROE is +0.02%, compared to KERN's ROE of -0.02%. Regarding short-term risk, OMDA is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
OMDA vs KERNW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas KERNW's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to KERNW's ROE of -0.02%. Regarding short-term risk, OMDA is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
OMDA vs LIFWW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas LIFWW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to LIFWW's ROE of +0.81%. Regarding short-term risk, OMDA is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
OMDA vs CMAXW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CMAXW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, OMDA is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
OMDA vs ZCMD Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ZCMD has a market cap of 16.6K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ZCMD trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, OMDA's ROE is +0.02%, compared to ZCMD's ROE of -0.54%. Regarding short-term risk, OMDA is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
OMDA vs ACONW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, ACONW has a market cap of 14.3K. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas ACONW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to ACONW's ROE of -0.63%. Regarding short-term risk, OMDA is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ACONW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
OMDA vs MSPRV Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MSPRV's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MSPRV's ROE of N/A. Regarding short-term risk, OMDA is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
OMDA vs MTBCP Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MTBCP's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MTBCP's ROE of +0.24%. Regarding short-term risk, OMDA is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
OMDA vs NAVA Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas NAVA's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, OMDA is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for OMDA.Check NAVA's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
OMDA vs MTBCO Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MTBCO's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MTBCO's ROE of +0.24%. Regarding short-term risk, OMDA is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check MTBCO's competition here
CareCloud, Inc. (NASDAQ: MTBC)
OMDA vs MTBC Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas MTBC's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MTBC's ROE of +0.30%. Regarding short-term risk, OMDA is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
OMDA vs CHNG Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CHNG's P/E ratio is -152.72. In terms of profitability, OMDA's ROE is +0.02%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, OMDA is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
OMDA vs CHNGU Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CHNGU's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, OMDA is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CHNGU's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
OMDA vs KURIU Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas KURIU's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, OMDA is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check KURIU's competition here
NantHealth, Inc. (NASDAQ: NH)
OMDA vs NH Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, NH has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas NH's P/E ratio is -0.12. In terms of profitability, OMDA's ROE is +0.02%, compared to NH's ROE of +0.35%. Regarding short-term risk, OMDA is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check NH's competition here
Castlight Health, Inc. (NYSE: CSLT)
OMDA vs CSLT Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CSLT's P/E ratio is -37.27. In terms of profitability, OMDA's ROE is +0.02%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, OMDA is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CSLT's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
OMDA vs AFFX Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas AFFX's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AFFX's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
OMDA vs IMS Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, IMS has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas IMS's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to IMS's ROE of +0.27%. Regarding short-term risk, OMDA is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
OMDA vs SMFRW Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas SMFRW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SMFRW's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
OMDA vs CNVY Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CNVY's P/E ratio is -71.50. In terms of profitability, OMDA's ROE is +0.02%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, OMDA is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CNVY's competition here
Cerner Corporation (NASDAQ: CERN)
OMDA vs CERN Comparison November 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 922.8M. In comparison, CERN has a market cap of 0. Regarding current trading prices, OMDA is priced at $15.09 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 65.54, whereas CERN's P/E ratio is 55.84. In terms of profitability, OMDA's ROE is +0.02%, compared to CERN's ROE of +0.14%. Regarding short-term risk, OMDA is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CERN's competition here